Concepedia

Recurrence or rebound of clinical relapses after discontinuation of natalizumab therapy in highly active MS patients

Per Soelberg Sørensen, Nils Koch‐Henriksen, Thor Petersen, Mads Ravnborg, Annette Oturai, Finn Sellebjerg

Journal of Neurology · 2014 · 141 citations · 23 references

DOI

Concepts

References

23

A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

Chris H. Polman, Paul O’Connor, Eva Havrdová et al. · New England Journal of Medicine · 2006 · 3.3K citations · Full text

, , +14

Natalizumab plus Interferon Beta-1a for Relapsing Multiple Sclerosis

Richard A. Rudick, William H. Stuart, Peter A. Calabresi et al. · New England Journal of Medicine · 2006 · 1.3K citations · Full text

, , +11

A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis

David H. Miller, Omar Khan, William Sheremata et al. · New England Journal of Medicine · 2003 · 1.2K citations · Full text

, , +16

Disease activity return during natalizumab treatment interruption in patients with multiple sclerosis

Paul O’Connor, Andrew Goodman, Ludwig Kappos et al. · Neurology · 2011 · 297 citations

, , +15

MS disease activity in RESTORE

Robert J. Fox, Bruce Cree, de Sèze et al. · Neurology · 2014 · 191 citations · Full text

, , +15